Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
Not Confirmed
Not Confirmed
16-18 March, 2026
Food Ingredients Chin... Food Ingredients China
Not Confirmed
Not Confirmed
17-19 March, 2026
Rare Disease SummitRare Disease Summit
Not Confirmed
Not Confirmed
17-19 March, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS






Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
16-18 March, 2026
Food Ingredients Chin... Food Ingredients China
Industry Trade Show
Not Confirmed
17-19 March, 2026
Rare Disease SummitRare Disease Summit
Industry Trade Show
Not Confirmed
17-19 March, 2026
Digital content

23 Jan 2026
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219048
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
Numbrino (Cocaine HCl) is a small molecule drug candidate, which is currently being evaluated in Phase III clinical studies for the treatment of Anesthesia, Local.
Lead Product(s): Cocaine Hydrochloride
Therapeutic Area: Neurology Brand Name: Numbrino
Study Phase: Phase IIIProduct Type: Controlled Substance
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable December 17, 2025

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Cocaine Hydrochloride
Therapeutic Area : Neurology
Highest Development Status : Phase III
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Pharmacokinetics, Safety, and Tolerability of GOPRELTO and NUMBRINO in Pediatric Nasal Procedures
Details : Numbrino (Cocaine HCl) is a small molecule drug candidate, which is currently being evaluated in Phase III clinical studies for the treatment of Anesthesia, Local.
Product Name : Numbrino
Product Type : Controlled Substance
Upfront Cash : Inapplicable
December 17, 2025

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : DISCN
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : CLEMASTINE FUMARATE
Dosage Strength : 2.68MG
Packaging :
Approval Date : 1993-10-31
Application Number : 73459
Regulatory Info : DISCN
Registration Country : USA

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : RX
Registration Country : USA
Dosage Form : SOLUTION;NASAL
Brand Name : NUMBRINO
Dosage Strength : 4%
Packaging :
Approval Date : 2020-01-10
Application Number : 209575
Regulatory Info : RX
Registration Country : USA

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : RX
Registration Country : USA
Dosage Form : INJECTABLE;INJECTION
Brand Name : GLYCOPYRROLATE
Dosage Strength : 0.2MG/ML
Packaging :
Approval Date : 2022-11-29
Application Number : 212871
Regulatory Info : RX
Registration Country : USA

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : RX
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : ISONIAZID
Dosage Strength : 100MG
Packaging :
Approval Date : 1997-06-26
Application Number : 40090
Regulatory Info : RX
Registration Country : USA

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : RX
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : ISONIAZID
Dosage Strength : 300MG
Packaging :
Approval Date : 1997-06-26
Application Number : 40090
Regulatory Info : RX
Registration Country : USA

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : RX
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : MONOKET
Dosage Strength : 20MG
Packaging :
Approval Date : 1993-06-30
Application Number : 20215
Regulatory Info : RX
Registration Country : USA

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : RX
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : MONOKET
Dosage Strength : 10MG
Packaging :
Approval Date : 1993-06-30
Application Number : 20215
Regulatory Info : RX
Registration Country : USA

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : RX
Registration Country : USA
Dosage Form : POWDER;INTRAMUSCULAR
Brand Name : OLANZAPINE
Dosage Strength : 10MG/VIAL
Packaging :
Approval Date : 2026-01-23
Application Number : 219048
Regulatory Info : RX
Registration Country : USA

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : RX
Registration Country : USA
Dosage Form : SOLUTION;INTRAVENOUS
Brand Name : SODIUM BICARBONATE
Dosage Strength : 50MEQ/50ML (1MEQ/ML)
Packaging :
Approval Date : 2023-06-15
Application Number : 216364
Regulatory Info : RX
Registration Country : USA

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : No
TE Code :
Dosage Form : TABLET; ORAL
Proprietary Name : CLEMASTINE FUMARATE
Dosage Strength : 2.68MG
Approval Date : 1993-10-31
Application Number : 73459
RX/OTC/DISCN : DISCN
RLD : No
TE Code :

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : Yes
TE Code :
Dosage Form : SOLUTION; NASAL
Proprietary Name : NUMBRINO
Dosage Strength : 4%
Approval Date : 2020-01-10
Application Number : 209575
RX/OTC/DISCN : RX
RLD : Yes
TE Code :

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : No
TE Code : AP
Dosage Form : INJECTABLE; INJECTION
Proprietary Name : GLYCOPYRROLATE
Dosage Strength : 0.2MG/ML
Approval Date : 2022-11-29
Application Number : 212871
RX/OTC/DISCN : RX
RLD : No
TE Code : AP

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : No
TE Code : AA
Dosage Form : TABLET; ORAL
Proprietary Name : ISONIAZID
Dosage Strength : 100MG
Approval Date : 1997-06-26
Application Number : 40090
RX/OTC/DISCN : RX
RLD : No
TE Code : AA

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : No
TE Code : AA
Dosage Form : TABLET; ORAL
Proprietary Name : ISONIAZID
Dosage Strength : 300MG
Approval Date : 1997-06-26
Application Number : 40090
RX/OTC/DISCN : RX
RLD : No
TE Code : AA

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : Yes
TE Code : AB
Dosage Form : TABLET; ORAL
Proprietary Name : MONOKET
Dosage Strength : 20MG
Approval Date : 1993-06-30
Application Number : 20215
RX/OTC/DISCN : RX
RLD : Yes
TE Code : AB

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : Yes
TE Code : AB
Dosage Form : TABLET; ORAL
Proprietary Name : MONOKET
Dosage Strength : 10MG
Approval Date : 1993-06-30
Application Number : 20215
RX/OTC/DISCN : RX
RLD : Yes
TE Code : AB

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : No
TE Code : AP
Dosage Form : POWDER; INTRAMUSCULAR
Proprietary Name : OLANZAPINE
Dosage Strength : 10MG/VIAL
Approval Date : 2026-01-23
Application Number : 219048
RX/OTC/DISCN : RX
RLD : No
TE Code : AP

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : No
TE Code : AP
Dosage Form : SOLUTION; INTRAVENOUS
Proprietary Name : SODIUM BICARBONATE
Dosage Strength : 50MEQ/50ML (1MEQ/ML)
Approval Date : 2023-06-15
Application Number : 216364
RX/OTC/DISCN : RX
RLD : No
TE Code : AP

ABOUT THIS PAGE